XML 32 R19.htm IDEA: XBRL DOCUMENT
v3.22.1

STOCK-BASED COMPENSATION | 12 Months Ended
--- | ---
Jan. 29, 2022
Share-based Payment Arrangement [Abstract] |
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION The Company has several stock option plans which allow for granting of stock options to employees, executives, and directors. The Company has not granted any stock options since fiscal 2008 and there are currently no stock options outstanding. The Company also has a restricted stock plan that allows for the granting of non-vested shares of common stock to employees and executives and a restricted stock plan that allows for the granting of non-vested shares of common stock to non-employee directors. As of January 29, 2022, 1,010,883 shares were available for grant under the Company’s various restricted stock plans, of which 929,322 shares were available for grant to executive officers. Compensation expense was recognized during fiscal 2021, 2020, and 2019 for equity-based grants, based on the grant date fair value of the awards. The fair value of grants of non-vested common stock awards is the stock price on the date of grant. Information regarding the impact of compensation expense related to grants of non-vested shares of common stock is as follows:
| Fiscal Years Ended
| January 29, 2022 |  | January 30, 2021 |  | February 1, 2020
Stock-based compensation expense, before tax | $ | 9,273 |  |  | $ | 6,174 |  |  | $ | 3,764 |
Stock-based compensation expense, after tax | $ | 6,992 |  |  | $ | 4,698 |  |  | $ | 2,853 |
Non-vested shares of common stock granted during each of the past three fiscal years were granted pursuant to the Company’s 2005 Restricted Stock Plan and the Company’s 2008 Director Restricted Stock Plan. Shares granted under the 2005 Plan are typically "performance based" and vest over a period of four years, only upon certification by the Compensation Committee of the Board of Directors that the Company has achieved its pre-established performance targets for the fiscal year. Certain shares granted under the 2005 Plan, however, are "non-performance based" and vest over a period of four years without being subject to the achievement of performance targets. Shares granted under the 2008 Director Plan vest 25% on the date of grant and then in equal portions on each of the first three anniversaries of the date of grant. A summary of the Company’s stock-based compensation activity related to grants of non-vested shares of common stock for the fiscal year ended January 29, 2022 is as follows:
| Shares |  | Weighted Average Grant Date Fair Value
Non-Vested - beginning of year | 538,750 |  |  | $ | 22.28 |
Granted | 381,300 |  |  | 39.32 |
Forfeited | (60,380) |  |  | 31.45 |
Vested | (269,208) |  |  | 22.59 |
Non-Vested - end of year | 590,462 |  |  | $ | 32.20 |
As of January 29, 2022, there was $8,849 of unrecognized compensation expense related to grants of non-vested shares. It is expected that this expense will be recognized over a weighted average period of approximately 2.0 years. The total fair value of shares vested during fiscal 2021, 2020, and 2019 was $10,125, $6,834, and $4,329 respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration